Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6612 | 1464 | 26.2 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
482 | 3 | MULTIPLE MYELOMA//AMYLOIDOSIS//TRANSTHYRETIN | 23544 |
713 | 2 | MULTIPLE MYELOMA//MYELOMA//LENALIDOMIDE | 12863 |
6612 | 1 | FREE LIGHT CHAINS//MONOCLONAL GAMMOPATHY//SERUM FREE LIGHT CHAINS | 1464 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FREE LIGHT CHAINS | authKW | 878063 | 5% | 53% | 80 |
2 | MONOCLONAL GAMMOPATHY | authKW | 512068 | 8% | 20% | 124 |
3 | SERUM FREE LIGHT CHAINS | authKW | 464249 | 2% | 70% | 32 |
4 | MONOCLONAL PROTEIN | authKW | 343891 | 2% | 57% | 29 |
5 | IMMUNOFIXATION ELECTROPHORESIS | authKW | 343847 | 2% | 63% | 26 |
6 | MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE | authKW | 343516 | 4% | 31% | 54 |
7 | IMMUNOFIXATION | authKW | 342182 | 3% | 43% | 38 |
8 | MGUS | authKW | 333714 | 4% | 28% | 57 |
9 | SERUM PROTEIN ELECTROPHORESIS | authKW | 250492 | 2% | 39% | 31 |
10 | SMOLDERING MULTIPLE MYELOMA | authKW | 194415 | 1% | 55% | 17 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medical Laboratory Technology | 36151 | 26% | 0% | 382 |
2 | Hematology | 9044 | 24% | 0% | 356 |
3 | Oncology | 882 | 14% | 0% | 212 |
4 | Pathology | 788 | 7% | 0% | 105 |
5 | Medicine, General & Internal | 541 | 10% | 0% | 152 |
6 | Immunology | 472 | 10% | 0% | 151 |
7 | Medicine, Research & Experimental | 271 | 6% | 0% | 91 |
8 | Transplantation | 270 | 3% | 0% | 47 |
9 | Biochemical Research Methods | 208 | 5% | 0% | 72 |
10 | Chemistry, Analytical | 50 | 4% | 0% | 60 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MULTIPLE MYELOMA SECT | 108939 | 1% | 33% | 16 |
2 | JOSE CARRERAS IMMUNO GENE THER Y | 83415 | 1% | 50% | 8 |
3 | A SAMMONS CANC | 20856 | 0% | 100% | 1 |
4 | ANAL BIOCHEM GRP | 20856 | 0% | 100% | 1 |
5 | ANAL CENTRALIZZATO | 20856 | 0% | 100% | 1 |
6 | AREA PROT | 20856 | 0% | 100% | 1 |
7 | AZIENDA OSPED UNIV CITTA SALUTEE SCI TORINO | 20856 | 0% | 100% | 1 |
8 | BIOCHEMAMYLOIDOSIS MYELOMA UNIT | 20856 | 0% | 100% | 1 |
9 | BIOCHIM A NEUROBIOL | 20856 | 0% | 100% | 1 |
10 | BIOCHIM PR HUBERT DE VERNEUIL | 20856 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 19094 | 4% | 1% | 62 |
2 | CLINICAL CHEMISTRY | 15240 | 6% | 1% | 93 |
3 | ANNALS OF CLINICAL BIOCHEMISTRY | 11372 | 3% | 1% | 43 |
4 | ANNALES DE BIOLOGIE CLINIQUE | 8296 | 2% | 1% | 34 |
5 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 6985 | 1% | 2% | 16 |
6 | AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 4296 | 3% | 0% | 42 |
7 | BRITISH JOURNAL OF HAEMATOLOGY | 4116 | 4% | 0% | 52 |
8 | CLINICAL BIOCHEMISTRY | 3148 | 2% | 1% | 28 |
9 | AMERICAN JOURNAL OF HEMATOLOGY | 2710 | 2% | 0% | 28 |
10 | EUROPEAN JOURNAL OF HAEMATOLOGY | 2155 | 1% | 1% | 20 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAJKUMAR, SV , DIMOPOULOS, MA , PALUMBO, A , BLADE, J , MERLINI, G , MATEOS, MV , KUMAR, S , HILLENGASS, J , KASTRITIS, E , RICHARDSON, P , ET AL (2014) INTERNATIONAL MYELOMA WORKING GROUP UPDATED CRITERIA FOR THE DIAGNOSIS OF MULTIPLE MYELOMA.LANCET ONCOLOGY. VOL. 15. ISSUE 12. P. E538 -E548 | 46 | 52% | 173 |
2 | KEREN, DF , SCHROEDER, L , (2016) CHALLENGES OF MEASURING MONOCLONAL PROTEINS IN SERUM.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 54. ISSUE 6. P. 947 -961 | 46 | 87% | 2 |
3 | JACOBS, JFM , TATE, JR , MERLINI, G , (2016) IS ACCURACY OF SERUM FREE LIGHT CHAIN MEASUREMENT ACHIEVABLE?.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 54. ISSUE 6. P. 1021 -1030 | 41 | 87% | 3 |
4 | GRAZIANI, MS , MERLINI, G , (2014) SERUM FREE LIGHT CHAIN ANALYSIS IN THE DIAGNOSIS AND MANAGEMENT OF MULTIPLE MYELOMA AND RELATED CONDITIONS.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 14. ISSUE 1. P. 55 -66 | 60 | 71% | 7 |
5 | BHOLE, MV , SADLER, R , RAMASAMY, K , (2014) SERUM-FREE LIGHT-CHAIN ASSAY: CLINICAL UTILITY AND LIMITATIONS.ANNALS OF CLINICAL BIOCHEMISTRY. VOL. 51. ISSUE 5. P. 528 -542 | 51 | 68% | 7 |
6 | RAJKUMAR, SV , LANDGREN, O , MATEOS, MV , (2015) SMOLDERING MULTIPLE MYELOMA.BLOOD. VOL. 125. ISSUE 20. P. 3069 -3075 | 37 | 77% | 14 |
7 | KYLE, RA , SAN-MIGUEL, JF , MATEOS, MV , RAJKUMAR, SV , (2014) MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SMOLDERING MULTIPLE MYELOMA.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 28. ISSUE 5. P. 775 -+ | 44 | 77% | 7 |
8 | VAN DE DONK, NWCJ , MUTIS, T , PODDIGHE, PJ , LOKHORST, HM , ZWEEGMAN, S , (2016) DIAGNOSIS, RISK STRATIFICATION AND MANAGEMENT OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SMOLDERING MULTIPLE MYELOMA.INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. VOL. 38. ISSUE . P. 110 -122 | 44 | 72% | 0 |
9 | SINGH, G , (2016) SERUM FREE LIGHT CHAIN ASSAY AND KAPPA/LAMBDA RATIO PERFORMANCE IN PATIENTS WITHOUT MONOCLONAL GAMMOPATHIES HIGH FALSE-POSITIVE RATE.AMERICAN JOURNAL OF CLINICAL PATHOLOGY. VOL. 146. ISSUE 2. P. 207 -214 | 36 | 86% | 0 |
10 | CAERS, J , DE LARREA, CF , LELEU, X , HEUSSCHEN, R , ZOJER, N , DECAUX, O , KASTRITIS, E , MINNEMA, M , JURCZYSZYN, A , BEGUIN, Y , ET AL (2016) THE CHANGING LANDSCAPE OF SMOLDERING MULTIPLE MYELOMA: A EUROPEAN PERSPECTIVE.ONCOLOGIST. VOL. 21. ISSUE 3. P. 333 -342 | 35 | 78% | 1 |
Classes with closest relation at Level 1 |